Skip to main content
OpenTrials

Clinical trial condition

Non-Hodgkin's Lymphoma

Explore clinical trials studying Non-Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.

250 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Non-Hodgkin's Lymphoma trial results

Completed

A Study of Obinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02611323

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Memorial Healthcare System Pembroke, Florida, United States
  • Emory Univ Winship Cancer Inst Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Completed

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

NCT01696461

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +31 more
Locations
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

NCT03236857

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Disease Attributes, +28 more
Locations
  • Univ California, San Francisco /ID# 163460 San Francisco, California, United States
  • Children's Hospital Colorado /ID# 161551 Aurora, Colorado, United States
  • Children's Healthcare of Atlan /ID# 161552 Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute /ID# 163440 Boston, Massachusetts, United States
View all 31 locations
View Trial Details

Related conditions